Atlas Trials

Comparison of Vildagliptin vs. Glimepiride on Glucose Variability in Metformin Uncontrolled Type 2 Diabetic Patients

Clinical trial NCT01910441 · TERMINATED

Trial details

NCT number
NCT01910441
Sponsor
Novartis Pharmaceuticals
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2013-07-01
Primary completion
2014-09-01
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.